- Home
- SGHT vs NAUT Comparison
SGHT vs NAUT Comparison
Compare SGHT & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- NAUT
- Stock Information
- Founded
- SGHT 2011
- NAUT 2016
- Country
- SGHT United States
- NAUT United States
- Employees
- SGHT N/A
- NAUT N/A
- Industry
- SGHT Medical Specialities
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- SGHT Health Care
- NAUT Industrials
- Exchange
- SGHT Nasdaq
- NAUT Nasdaq
- Market Cap
- SGHT 193.2M
- NAUT 104.7M
- IPO Year
- SGHT 2021
- NAUT N/A
- Fundamental
- Price
- SGHT $4.58
- NAUT $1.12
- Analyst Decision
- SGHT Buy
- NAUT Strong Sell
- Analyst Count
- SGHT 8
- NAUT 1
- Target Price
- SGHT $4.21
- NAUT $1.75
- AVG Volume (30 Days)
- SGHT 165.8K
- NAUT 396.6K
- Earning Date
- SGHT 11-06-2025
- NAUT 10-28-2025
- Dividend Yield
- SGHT N/A
- NAUT N/A
- EPS Growth
- SGHT N/A
- NAUT N/A
- EPS
- SGHT N/A
- NAUT N/A
- Revenue
- SGHT $76,303,000.00
- NAUT N/A
- Revenue This Year
- SGHT N/A
- NAUT N/A
- Revenue Next Year
- SGHT $12.04
- NAUT N/A
- P/E Ratio
- SGHT N/A
- NAUT N/A
- Revenue Growth
- SGHT N/A
- NAUT N/A
- 52 Week Low
- SGHT $2.03
- NAUT $0.62
- 52 Week High
- SGHT $6.08
- NAUT $2.99
- Technical
- Relative Strength Index (RSI)
- SGHT 69.58
- NAUT 68.49
- Support Level
- SGHT $3.22
- NAUT $0.95
- Resistance Level
- SGHT $3.60
- NAUT $1.24
- Average True Range (ATR)
- SGHT 0.25
- NAUT 0.09
- MACD
- SGHT 0.14
- NAUT 0.02
- Stochastic Oscillator
- SGHT 68.87
- NAUT 71.45
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.